Related Experiment Video
Updated: Nov 10, 2025

08:41
Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials
Published on: August 13, 2019
8.5K
Acid Dentin Lysate Failed to Modulate Bone Formation in Rat Calvaria Defects
Jila Nasirzade1, Karol Alí Apaza Alccayhuaman1, Zahra Kargarpour1
1Department of Oral Biology, Medical University of Vienna, 1090 Vienna, Austria.
Biology
|April 3, 2021
Summary
Acid dentin lysate (ADL) from tooth roots did not enhance bone regeneration in rat calvarial defects. This study found no significant differences in bone formation between ADL-treated and control groups.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Oral and Maxillofacial Surgery
Background:
- Autogenous tooth roots are explored as grafting materials for alveolar bone augmentation.
- Tooth roots share similarities with bone grafts, suggesting potential release of growth factors from dentin by osteoclasts.
Purpose of the Study:
- To investigate if acid dentin lysate (ADL) influences bone formation in critical-size calvarial defects.
- To test the hypothesis that osteoclast-mediated release of dentin growth factors promotes bone regeneration.
Main Methods:
- Collagen membranes were treated with ADL or control medium, then lyophilized.
- These membranes were used to cover critical-size calvarial defects in rats.
- Bone regeneration was assessed after four weeks using micro-computed tomography and histological analysis.
Main Results:
- Micro-CT showed no significant difference in bone defect coverage between ADL (91%) and control (94%) groups.
- Bone volume (BV) was comparable between the ADL (5.7 mm³) and control (5.7 mm³) groups.
- Histomorphometry confirmed similar bone area in both ADL (2.1 mm²) and control (2.0 mm²) groups.
Conclusions:
- Acid dentin lysate lyophilized onto collagen membranes did not significantly enhance bone formation in rat calvarial defects.
- The findings suggest ADL, under these experimental conditions, does not modulate osteogenesis in critical-size bone defects.

